Highest-Volume Intravitreal Injection (Anti-VEGF) Surgeons in New York (2026 update)

298 New York providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in 2024. The top 10 by case volume are below — the full ranked list, CSV export and competitor-payment intel are available with a DocVol subscription ($199/mo, cancel anytime).

Database refreshed July 2026Live NPPES registryⓘ sources
#SurgeonLocationMedicare cases (2024)
1Jonathan Jonisch, MDGreat Neck, NY3,500
2Roy Arogyasami, M.D.Plattsburgh, NY3,390
3Brett RosenblattGreat Neck, NY2,982
4Paul Guerriero, M.D.Orangeburg, NY2,862
5Kenneth GrahamGreat Neck, NY2,862
6Craig Fern, M.D.Mount Kisco, NY2,774
7Jamin Brown, M.D.Liverpool, NY2,671
8Glenn Stoller, M.D.Rockville Centre, NY2,669
9Kevin Rosenberg, MDLiverpool, NY2,371
10Tahsin Choudhury, M.D.Liverpool, NY2,192

288 more New York surgeons in the full list

Plus: who already pays them (Stryker? Medtronic? Arthrex?), CSV export for your CRM, and every other state and procedure.

Search the full database

Frequently asked questions

How many surgeons perform Intravitreal Injection (Anti-VEGF) in New York?
298 New York providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in CY2024. CMS suppresses providers with 10 or fewer Medicare patients, so the true count is somewhat higher.
Where does this data come from?
CMS Medicare Physician & Other Practitioners (fee-for-service Part B claims, CY2024, released May 2026) and CMS Open Payments. Both are official U.S. federal datasets.
Does this include all of a surgeon's cases?
No — it covers traditional Medicare only (no Medicare Advantage, commercial, or Medicaid claims). Absolute volumes undercount total practice, but the ranking of high- vs low-volume surgeons is a strong targeting signal.

Related Retina rankings in New York